FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Herman Gold

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Dogs
Rabbits

Procedures

Anatomy

Co-author Network

Publications

TOP 3
Aloke V Finn; Jae S Oh; Michael Hendricks; Maureen Daher; Enrico Cagliero; Raphael M Byrne; Jeffrey Nadelson; Johanna Crimins; Adnan Kastrati; Albert Schömig; Olga Bruskina; Igor Palacios; Michael C John; Herman K Gold
Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo.
Michael Joner; Katsumi Morimoto; Hiroaki Kasukawa; Kristin Steigerwald; Sabine Merl; Gaku Nakazawa; Michael C John; Aloke V Finn; Eduardo Acampado; Frank D Kolodgie; Herman K Gold; Renu Virmani
Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.
Michael C John; Rainer Wessely; Adnan Kastrati; Albert Schömig; Michael Joner; Mayu Uchihashi; Johanna Crimins; Scott Lajoie; Frank D Kolodgie; Herman K Gold; Renu Virmani; Aloke V Finn
Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Herman Gold (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Aloke V Finn; Jae S Oh; Michael Hendricks; Maureen Daher; Enrico Cagliero; Raphael M Byrne; Jeffrey Nadelson; Johanna Crimins; Adnan Kastrati; Albert Schömig; Olga Bruskina; Igor Palacios; Michael C John; Herman K Gold
Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo.
American heart journal 2009;157(2):383.e1-8.
2008: Michael Joner; Katsumi Morimoto; Hiroaki Kasukawa; Kristin Steigerwald; Sabine Merl; Gaku Nakazawa; Michael C John; Aloke V Finn; Eduardo Acampado; Frank D Kolodgie; Herman K Gold; Renu Virmani
Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(11):1960-6.
2008: Michael C John; Rainer Wessely; Adnan Kastrati; Albert Schömig; Michael Joner; Mayu Uchihashi; Johanna Crimins; Scott Lajoie; Frank D Kolodgie; Herman K Gold; Renu Virmani; Aloke V Finn
Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.
JACC. Cardiovascular interventions 2008;1(5):535-44.
2008: Gaku Nakazawa; Aloke V Finn; Michael Joner; Elena Ladich; Robert Kutys; Erik K Mont; Herman K Gold; Allen P Burke; Frank D Kolodgie; Renu Virmani
Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study.
Circulation 2008;118(11):1138-45.
2008: Ricardo Cury; Koen Nieman; Michael Shapiro; Javed Butler; Cesar H Nomura; Maros Ferencik; Udo Hoffmann; Suhny Abbara; Davinder S Jassal; Tsunehiro Yasuda; Herman K Gold; Ik-Kyung Jang; Thomas J Brady
Comprehensive assessment of myocardial perfusion defects, regional wall motion, and left ventricular function by using 64-section multidetector CT.
Radiology 2008;248(2):466-75.
2008: Michael Joner; Gaku Nakazawa; Aloke V Finn; Shawn Chin Quee; Leslie Coleman; Eduardo Acampado; Patricia S Wilson; Kristi Skorija; Qi Cheng; Xin Xu; Herman K Gold; Frank D Kolodgie; Renu Virmani
Endothelial cell recovery between comparator polymer-based drug-eluting stents.
Journal of the American College of Cardiology 2008;52(5):333-42.
2008: Koen Nieman; Michael Shapiro; Maros Ferencik; Cesar H Nomura; Suhny Abbara; Udo Hoffmann; Herman K Gold; Ik-Kyung Jang; Thomas J Brady; Ricardo Cury
Reperfused myocardial infarction: contrast-enhanced 64-Section CT in comparison to MR imaging.
Radiology 2008;247(1):49-56.
2007: Aloke V Finn; Herman K Gold
Total erythrocyte membrane cholesterol: a marker of plaque instability?
Nature clinical practice. Cardiovascular medicine 2007;4(12):646-7.
2007: Rakesh K Jain; Aloke V Finn; Frank D Kolodgie; Herman K Gold; Renu Virmani
Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization.
Nature clinical practice. Cardiovascular medicine 2007;4(9):491-502.
2007: Michael Shapiro; Koen Nieman; Khurram Nasir; Cesar H Nomura; Ammar Sarwar; Maros Ferencik; Suhny Abbara; Udo Hoffmann; Udo Hoffman; Herman K Gold; Ik-Kyung Jang; Thomas J Brady; Ricardo Cury
Utility of cardiovascular magnetic resonance to predict left ventricular recovery after primary percutaneous coronary intervention for patients presenting with acute ST-segment elevation myocardial infarction.
The American journal of cardiology 2007;100(2):211-6.
2007: Aloke V Finn; Gaku Nakazawa; Michael Joner; Frank D Kolodgie; Erik K Mont; Herman K Gold; Renu Virmani
Vascular responses to drug eluting stents: importance of delayed healing.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(7):1500-10.
2007: Tej N Sheth; Jonathan D Dodd; Udo Hoffmann; Suhny Abbara; Aloke Finn; Herman K Gold; Thomas J Brady; Ricardo Cury
Coronary stent assessability by 64 slice multi-detector computed tomography.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;69(7):933-8.
2007: Aloke V Finn; Michael Joner; Gaku Nakazawa; Frank D Kolodgie; John Newell; Mike C John; Herman K Gold; Renu Virmani
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Circulation 2007;115(18):2435-41.
2007: Michael Joner; Andrew Farb; Qi Cheng; Aloke V Finn; Eduardo Acampado; Allen P Burke; Kristi Skorija; Wendy Creighton; Frank D Kolodgie; Herman K Gold; Renu Virmani
Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(1):182-9.
2006: Koen Nieman; Ricardo Cury; Maros Ferencik; Cesar H Nomura; Suhny Abbara; Udo Hoffmann; Herman K Gold; Ik-Kyung Jang; Thomas J Brady
Differentiation of recent and chronic myocardial infarction by cardiac computed tomography.
The American journal of cardiology 2006;98(3):303-8.
2006: Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
Journal of the American College of Cardiology 2006;48(1):193-202.
2005: Renu Virmani; Frank D Kolodgie; Allen P Burke; Aloke V Finn; Herman K Gold; Thomas N Tulenko; Steven P Wrenn; Jagat Narula
Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(10):2054-61.
2005: Craig A Thompson; Vivek K Reddy; Ashok Srinivasan; Stuart Houser; Motoya Hayase; Andre Davila; Eugene Pomerantsev; Joseph P Vacanti; Herman K Gold
Left ventricular functional recovery with percutaneous, transvascular direct myocardial delivery of bone marrow-derived cells.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2005;24(9):1385-92.
2005: Aloke V Finn; Frank D Kolodgie; Jan Harnek; LJ Guerrero; Eduardo Acampado; Kirubel Tefera; Kristi Skorija; Deena K Weber; Herman K Gold; Renu Virmani
Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents.
Circulation 2005;112(2):270-8.
2005: Aloke V Finn; Igor F Palacios; Adnan Kastrati; Herman K Gold
Drug-eluting stents for diabetes mellitus: a rush to judgment?
Journal of the American College of Cardiology 2005;45(4):479-83.
2004: Frank D Kolodgie; Renu Virmani; Allen P Burke; Andrew Farb; Deena K Weber; Robert Kutys; Aloke V Finn; Herman K Gold
Pathologic assessment of the vulnerable human coronary plaque.
Heart (British Cardiac Society) 2004;90(12):1385-91.
2004: Aloke V Finn; Herman K Gold
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent in patients with diabetes mellitus.
Circulation 2004;110(12):e318-9; author reply e318-9.
2004: Mark H Rubenstein; Aloke V Finn; Robert C Leinbach; Stanley Hollenbach; H Thomas Aretz; Renu Virmani; Herman K Gold
Short-term intravenous eptifibatide infusion combined with reduced dose recombinant tissue plasminogen activator inhibits platelet recruitment at sites of coronary artery injury.
Journal of the American College of Cardiology 2004;43(2):287-94.
2003: Frank D Kolodgie; Artiom Petrov; Renu Virmani; Navneet Narula; Johan W Verjans; Deena K Weber; Dagmar Hartung; Neil Steinmetz; Jean-Luc Vanderheyden; Mani A Vannan; Herman K Gold; Chris P M Reutelingsperger; Leo Hofstra; Jagat Narula
Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque.
Circulation 2003;108(25):3134-9.
2003: Frank D Kolodgie; Herman K Gold; Allen P Burke; David R Fowler; Howard S Kruth; Deena K Weber; Andrew Farb; LJ Guerrero; Motoya Hayase; Robert Kutys; Jagat Narula; Aloke V Finn; Renu Virmani
Intraplaque hemorrhage and progression of coronary atheroma.
The New England journal of medicine 2003;349(24):2316-25.
2003: Craig A Thompson; Boris A Nasseri; Joshua Makower; Stuart Houser; Michael McGarry; Theodore Lamson; Irina Pomerantseva; John Y Chang; Herman K Gold; Joseph P Vacanti; Stephen N Oesterle
Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation.
Journal of the American College of Cardiology 2003;41(11):1964-71.
2002: Aloke V Finn; Herman K Gold; Anita Tang; Deena K Weber; Thomas N Wight; Allen Clermont; Renu Virmani; Frank D Kolodgie
A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic diseases.
Journal of vascular research 2002;39(5):414-25.
2001: Frank D Kolodgie; Allen P Burke; Andrew Farb; Herman K Gold; J Yuan; Jagat Narula; Aloke V Finn; Renu Virmani
The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes.
Current opinion in cardiology 2001;16(5):285-92.
2001: U Schmidt; R O Han; Thomas G DiSalvo; J Luis Guerrero; Herman K Gold; Warren M Zapol; Kenneth D Bloch; Marc J Semigran
Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition.
Journal of the American College of Cardiology 2001;37(7):1981-8.
1998: Nasser A Mahdi; AZ Pathan; Lari C Harrell; MN Leon; J Lopez; Atul Butte; Margaret Ferrell; Herman K Gold; Igor F Palacios
Directional coronary atherectomy for the treatment of Palmaz-Schatz in-stent restenosis.
The American journal of cardiology 1998;82(11):1345-51.
1997: Herman K Gold; H D Garabedian; Robert Dinsmore; LJ Guerrero; Joaquin E Cigarroa; Igor F Palacios; Robert C Leinbach
Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Observations in animals and humans.
Circulation 1997;95(7):1755-9.
1996: Pedro R Moreno; Victor Bernardi; J López-Cuéllar; J B Newell; C McMellon; Herman K Gold; Igor F Palacios; Valentin Fuster; J T Fallon
Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina.
Circulation 1996;94(12):3098-102.
1996: Pedro R Moreno; Victor Bernardi; J López-Cuéllar; A M Murcia; Igor F Palacios; Herman K Gold; R Mehran; S K Sharma; Y Nemerson; Valentin Fuster; J T Fallon
Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes.
Circulation 1996;94(12):3090-7.
1996: C Adrie; Kenneth D Bloch; Pedro R Moreno; William E Hurford; J Luis Guerrero; R Holt; Warren M Zapol; Herman K Gold; Marc J Semigran
Inhaled nitric oxide increases coronary artery patency after thrombolysis.
Circulation 1996;94(8):1919-26.
1996: A J Smith; R E Holt; J B Fitzpatrick; Igor F Palacios; Herman K Gold; W Werner; E G Bovill; Valentin Fuster; I K Jang
Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty.
American heart journal 1996;131(3):434-9.
1994: Désiré Collen; Jean Marie Stassen; T Yasuda; Canio Refino; N Paoni; B Keyt; Tania Roskams; J L Guerrero; H Roger Lijnen; Herman K Gold
Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
Thrombosis and haemostasis 1994;72(1):98-104.
1994: R G Kiss; Jean Marie Stassen; Hans Deckmyn; Tania Roskams; Herman K Gold; Edward F Plow; Désiré Collen
Contribution of platelets and the vessel wall to the antithrombotic effects of a single bolus injection of Fab fragments of the antiplatelet GPIIb/IIIa antibody 7E3 in a canine arterial eversion graft preparation.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(3):375-80.
1994: R G Kiss; H R Lu; Tania Roskams; I K Jang; Edward F Plow; Herman K Gold; Désiré Collen
Time course of the effects of a single bolus injection of F(ab')2 fragments of the antiplatelet GPIIb/IIIa antibody 7E3 on arterial eversion graft occlusion, platelet aggregation, and bleeding time in dogs.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(3):367-74.
1994: H D Garabedian; Herman K Gold; J B Newell; Désiré Collen; J N Hagstrom; E G Bovill
Accelerated thrombin generation during anticoagulation in patients with unstable angina pectoris.
Blood 1994;83(4):1155.
1994: Désiré Collen; H R Lu; Jean Marie Stassen; Ingrid Vreys; T Yasuda; S Bunting; Herman K Gold
Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis.
Thrombosis and haemostasis 1994;71(1):95-102.
1993: C Kohmura; Herman K Gold; T Yasuda; R Holt; M A Nedelman; J Luis Guerrero; H F Weisman; Désiré Collen
A chimeric murine/human antibody Fab fragment directed against the platelet GPIIb/IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue-type plasminogen activator in baboons.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(12):1837-42.
1993: T Yasuda; Herman K Gold; C Kohmura; L Guerrero; H Yaoita; J T Fallon; Stuart Bunting; Désiré Collen
Intravenous and endobronchial administration of G4120, a cyclic Arg-Gly-Asp-containing platelet GPIIb/IIIa receptor-blocking pentapeptide, enhances and sustains coronary arterial thrombolysis with rt-PA in a canine preparation.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(5):738-47.
1993: Herman K Gold; F W Torres; H D Garabedian; W Werner; I K Jang; A Khan; J N Hagstrom; T Yasuda; R C Leinbach; J B Newell
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
Journal of the American College of Cardiology 1993;21(5):1039-47.
1992: Y Imura; Jean Marie Stassen; Ingrid Vreys; E Lesaffre; Herman K Gold; Désiré Collen
Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model.
Thrombosis and haemostasis 1992;68(3):336-40.
1992: I K Jang; Herman K Gold; R C Leinbach; J T Fallon; Désiré Collen; Josiah N Wilcox
Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(8):948-54.
1992: H R Lu; Herman K Gold; Z Wu; T Yasuda; Patrick Pauwels; H J Rapold; M Napier; S Bunting; Désiré Collen
G4120, an Arg-Gly-Asp containing pentapeptide, enhances arterial eversion graft recanalization with recombinant tissue-type plasminogen activator in dogs.
Thrombosis and haemostasis 1992;67(6):686-91.
1992: H D Garabedian; Herman K Gold
Coronary thrombolysis, conjunctive heparin infusion, and the effect on systemic thrombin activity.
Circulation 1992;85(3):1205-7.
1991: T Saito; T Yasuda; Herman K Gold; R Leinbach; E Livni; David R Elmaleh; R Callahan; M Barlai-Kovach; R Wilkinson; Alan J Fischman
Differentiation of regional perfusion and fatty acid uptake in zones of myocardial injury.
Nuclear medicine communications 1991;12(8):663-75.
1991: Herman K Gold; T Yasuda; I K Jang; J Luis Guerrero; J T Fallon; R C Leinbach; Désiré Collen
Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus.
Circulation 1991;83(6 Suppl):IV26-40.
1991: H D Garabedian; Herman K Gold; R C Leinbach; T A Svizzero; D M Finkelstein; J Luis Guerrero; Désiré Collen
Bleeding time prolongation and bleeding during infusion of recombinant tissue-type plasminogen activator in dogs: potentiation by aspirin and reversal with aprotinin.
Journal of the American College of Cardiology 1991;17(5):1213-22.
1991: T Yasuda; Herman K Gold; R C Leinbach; H Yaoita; J T Fallon; L Guerrero; M A Napier; Stuart Bunting; Désiré Collen
Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation.
Circulation 1991;83(3):1038-47.
1990: T Yasuda; Herman K Gold; R C Leinbach; T Saito; J Luis Guerrero; I K Jang; R Holt; J T Fallon; Désiré Collen
Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody.
Journal of the American College of Cardiology 1990;16(7):1728-35.
1990: I K Jang; Herman K Gold; R C Leinbach; J T Fallon; Désiré Collen
In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator.
Circulation research 1990;67(6):1552-61.
1990: T Yasuda; Herman K Gold; H Yaoita; R C Leinbach; J Luis Guerrero; I K Jang; R Holt; J T Fallon; Désiré Collen
Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation.
Journal of the American College of Cardiology 1990;16(3):714-22.
1990: Herman K Gold; Lawrence W Gimple; T Yasuda; R C Leinbach; W Werner; R Holt; R Jordan; H Berger; Désiré Collen; Barry S Coller
Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.
The Journal of clinical investigation 1990;86(2):651-9.
1990: I K Jang; Herman K Gold; A A Ziskind; R C Leinbach; J T Fallon; Désiré Collen
Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.
Circulation 1990;81(1):219-25.
1990: J A Johns; M B Leavitt; J B Newell; T Yasuda; R C Leinbach; Herman K Gold; D Finkelstein; R E Dinsmore
Quantitation of acute myocardial infarct size by nuclear magnetic resonance imaging.
Journal of the American College of Cardiology 1990;15(1):143-9.
1990: Désiré Collen; Herman K Gold
New developments in thrombolytic therapy.
Thrombosis research. Supplement 1990;10():105-31.
1990: Désiré Collen; Herman K Gold
New developments in thrombolytic therapy.
Advances in experimental medicine and biology 1990;281():333-54.
1990: T Yasuda; Herman K Gold
Acute myocardial infarction and thrombolytic therapy.
Thrombosis research. Supplement 1990;10():73-9.
1989: Lawrence W Gimple; Herman K Gold; R C Leinbach; Barry S Coller; W Werner; T Yasuda; J A Johns; A A Ziskind; D Finkelstein; Désiré Collen
Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
Circulation 1989;80(3):581-8.
1989: T Yasuda; Herman K Gold; J T Fallon; R C Leinbach; H D Garabedian; J Luis Guerrero; Désiré Collen
A canine model of coronary artery thrombosis with superimposed high grade stenosis for the investigation of rethrombosis after thrombolysis.
Journal of the American College of Cardiology 1989;13(6):1409-14.
1989: I K Jang; Herman K Gold; A A Ziskind; J T Fallon; R E Holt; R C Leinbach; J W May; Désiré Collen
Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis.
Circulation 1989;79(4):920-8.
1989: D Spriggs; Herman K Gold; Y Hashimoto; E Van Houtte; Jos Vermylen; Désiré Collen
Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis model.
Thrombosis and haemostasis 1989;61(1):93-6.
1989: A A Ziskind; Herman K Gold; T Yasuda; M Kanke; J Luis Guerrero; J T Fallon; T Saito; Désiré Collen
Synergistic combinations of recombinant human tissue-type plasminogen activator and human single-chain urokinase-type plasminogen activator. Effect on thrombolysis and reocclusion in a canine coronary artery thrombosis model with high-grade stenosis.
Circulation 1989;79(2):393-9.
1988: J A Johns; Herman K Gold; R C Leinbach; T Yasuda; Lawrence W Gimple; W Werner; D Finkelstein; J Newell; A A Ziskind; Désiré Collen
Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator.
Circulation 1988;78(3):546-56.
1988: J M McComb; Herman K Gold; R C Leinbach; J B Newell; Jeremy N Ruskin; H Garan
Electrically induced ventricular arrhythmias in acute myocardial infarction treated with thrombolytic agents.
The American journal of cardiology 1988;62(4):186-91.
1988: H D Garabedian; Herman K Gold; R C Leinbach; T Yasuda; J A Johns; D Thornton; Désiré Collen
Laboratory monitoring of hemostasis during thrombolytic therapy with recombinant human tissue-type plasminogen activator.
Thrombosis research 1988;50(1):121-33.
1988: H D Garabedian; Herman K Gold; T Yasuda; J A Johns; D M Finkelstein; R J Gaivin; C Cobbaert; R C Leinbach; Désiré Collen
Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography.
Journal of the American College of Cardiology 1988;11(4):729-34.
1988: T Yasuda; Herman K Gold; J T Fallon; R C Leinbach; J Luis Guerrero; L E Scudder; M Kanke; D Shealy; M J Ross; Désiré Collen
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.
The Journal of clinical investigation 1988;81(4):1284-91.
1988: Herman K Gold; Barry S Coller; T Yasuda; T Saito; J T Fallon; J Luis Guerrero; R C Leinbach; A A Ziskind; Désiré Collen
Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation.
Circulation 1988;77(3):670-7.
1988: Désiré Collen; D C Stump; Herman K Gold
Thrombolytic therapy.
Annual review of medicine 1988;39():405-23.
1988: Herman K Gold; R C Leinbach
Thrombolysis in acute myocardial infarction.
Chest 1988;93(1 Suppl):10S-12S.
1987: Ban-An Khaw; T Yasuda; Herman K Gold; R C Leinbach; J A Johns; M Kanke; M Barlai-Kovach; Harry W Strauss; E Haber
Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(11):1671-8.
1987: Herman K Gold; J A Johns; R C Leinbach; T Yasuda; Désiré Collen
Thrombolytic therapy for unstable angina pectoris: rationale and results.
Journal of the American College of Cardiology 1987;10(5 Suppl B):91B-95B.
1987: Herman K Gold; J A Johns; R C Leinbach; T Yasuda; E Grossbard; R Zusman; Désiré Collen
A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.
Circulation 1987;75(6):1192-9.
1987: H D Garabedian; Herman K Gold; R C Leinbach; J A Johns; T Yasuda; M Kanke; Désiré Collen
Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.
Journal of the American College of Cardiology 1987;9(3):599-607.
1986: H D Garabedian; Herman K Gold; R C Leinbach; T Yasuda; J A Johns; Désiré Collen
Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis.
The American journal of cardiology 1986;58(9):673-9.
1986: Ban-An Khaw; Herman K Gold; T Yasuda; R C Leinbach; M Kanke; J T Fallon; M Barlai-Kovach; Harry W Strauss; F Sheehan; E Haber
Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody.
Circulation 1986;74(3):501-8.
1986: Herman K Gold; R C Leinbach; H D Garabedian; T Yasuda; J A Johns; E B Grossbard; I Palacios; Désiré Collen
Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.
Circulation 1986;73(2):347-52.
1984: Herman K Gold; J T Fallon; T Yasuda; R C Leinbach; B A Khaw; J B Newell; J L Guerrero; F M Vislosky; C F Hoyng; E Grossbard
Coronary thrombolysis with recombinant human tissue-type plasminogen activator.
Circulation 1984;70(4):700-7.